Alimta

... Salt Lake Tribune - Business WORLD CLASSIFIEDS Quick Search Enter search term Advanced Search Business Stocks WSJ Sunday News Contents Past Content Photos Obituaries Archives Utah Politics Drought Closeup Columnists TribTalk Forums Weather Ski Report Opinion Bagley Cartoons Editorials Commentary Public Forum Sports Real Salt Lake Stingers Utah Jazz College Sports Prep Sports Features Film Finder Arts Travel Home & Family Health & Science Food Outdoors The Mix Faith Entertainment Lifestyle Shopping Classifieds Retail Ads Cars/RVs Real Estate Jobs Education Guide Bride Guide Utah City Guide Hotel Rooms Grocery Guru Fantasy Sports Buy/Sell Tickets Advertising Info Bus./Industry Utah Community News Extras TribTalk Forums Not in Print NIE Reader Panel Crossword Services Help Desk FAQ Contact Us Subscribe Privacy Policy Link To Article Print Article Email Article Article Last Updated: 04/13/2005 11:29:54 PM Modest Q1 looms for drug makers By Greg Groeller Dow Jones Newswires rimmer:td NEW YORK - U.S.

drug makers are expected to report a lackluster first quarter, reflecting an ongoing struggle with product withdrawals, a dearth of new drugs in the pipeline and increased competition from generics.

Profits at most major drug makers will be driven by the companies' ability to hold down costs, rather than by bringing in more revenue from...

... Minister's hands tied on drug subsidy decision.

14/04/2005.

ABC News Online News Home Top Stories Just In World Australia/Local Business Politics Weather Sport Health Arts Sci-Tech Environment Rural Indigenous Offbeat In-Depth Forums Services Help/Site Map Programs - RADIO - AM Back.

Briefing Business Report Corresp.

Report Go Asia Pacific NewsRadio PM Sunday Profile World Today - TV - 7.30 Report Asia Pacific Focus Aust.

Story Bus.

Breakfast Foreign Corresp.

Four Corners Inside Business Insiders Landline Lateline Stateline Print Email Last Update: Thursday, April 14, 2005.

2:47pm (AEST) No power: A spokeswoman for Mr Abbott says he cannot intervene.

[File photo] (Lateline) Minister's hands tied on drug subsidy decision A spokeswoman for federal Health Minister Tony Abbott says the Government has no power to influence the outcomes of decisions made by the Pharmaceutical Benefits Scheme (PBS) advisory committee.

Groups representing asbestos-related cancer sufferers have criticised the committee's decision not to subsidise an expensive new drug called Alinta.

Sufferers say it is the only effective treatment for mesothelioma as it modestl...

... Mesothelioma sufferers in The 41-year-old former carpenter, diagnosed with the deadly asbestos-related cancer last year, joined a chorus of asbestos disease victims and doctors calling on the federal government to give all mesothelioma patients access to the drug.

The chemotherapy drug About 600 people a year in Australia develop mesothelioma - a rare form of lung cancer which is caused only by asbestos exposure.

Symptoms include severe pain, difficulty breathing, weight loss and fatigue.

Mr Lorizio accessed the drug through the NSW Dust Disease Tribunal, but said it was unlikely most mesothelioma sufferers could afford the $15,000 price tag attached to the tre...